THE SIZE OF CLINICAL-TRIALS IN CANCER-RESEARCH - WHAT ARE THE CURRENT NEEDS

被引:21
作者
FREEDMAN, LS [1 ]
机构
[1] MRC,CANC TRIALS OFF,5 SHAFTESBURY RD,CAMBRIDGE CB2 2BW,ENGLAND
关键词
D O I
10.1038/bjc.1989.79
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:396 / 400
页数:5
相关论文
共 21 条
[2]  
BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO
[3]  
2-C
[4]   AMPUTATION AND ADRIAMYCIN IN PRIMARY OSTEOSARCOMA [J].
CORTES, EP ;
HOLLAND, JF ;
WANG, JJ ;
SINKS, LF ;
BLOM, J ;
SENN, H ;
BANK, A ;
GLIDEWELL, O .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) :998-1000
[5]   CURRENT STATUS OF INTRAVESICAL CHEMOTHERAPY TRIALS IN THE EORTC-UROLOGICAL-GROUP - AN OVERVIEW [J].
DENIS, L ;
BOUFFIOUX, C ;
KURTH, KH ;
DEBRUYNE, F ;
SYLVESTER, R ;
DEPAUW, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 :S67-S71
[6]  
EILBER FR, 1978, CANCER TREAT REP, V62, P213
[7]  
ELLENBERG SS, 1985, CANCER TREAT REP, V69, P1147
[8]  
HAYBITTLE J, 1988, BRIT J CANCER, V57, P521
[9]   ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMA [J].
JAFFE, N ;
FREI, E ;
TRAGGIS, D ;
BISHOP, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) :994-997
[10]   THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY [J].
LINK, MP ;
GOORIN, AM ;
MISER, AW ;
GREEN, AA ;
PRATT, CB ;
BELASCO, JB ;
PRITCHARD, J ;
MALPAS, JS ;
BAKER, AR ;
KIRKPATRICK, JA ;
AYALA, AG ;
SHUSTER, JJ ;
ABELSON, HT ;
SIMONE, JV ;
VIETTI, TJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) :1600-1606